Corriente Advisors as of Dec. 31, 2019
Portfolio Holdings for Corriente Advisors
Corriente Advisors holds 17 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maxar Technologies | 22.6 | $42M | 2.7M | 15.67 | |
| Reata Pharmaceuticals Inc Cl A | 21.1 | $39M | 192k | 204.43 | |
| Virgin Galactic Holdings Inc virgin galactic holdings (SPCE) | 15.0 | $28M | 2.4M | 11.55 | |
| Uniqure Nv (QURE) | 9.7 | $18M | 253k | 71.66 | |
| Turning Point Therapeutics I | 9.5 | $18M | 285k | 62.29 | |
| Intelsat Sa | 6.2 | $12M | 1.6M | 7.03 | |
| Cue Biopharma (CUE) | 2.4 | $4.5M | 285k | 15.87 | |
| Catabasis Pharmaceuticals Ord | 2.0 | $3.6M | 617k | 5.91 | |
| Global Blood Therapeutics In | 1.7 | $3.2M | 40k | 79.50 | |
| Eiger Biopharmaceuticals | 1.6 | $3.0M | 204k | 14.90 | |
| Virgin Galactic Holdings Inc virgin galactic holding-cw22 | 1.6 | $2.9M | 253k | 11.55 | |
| Aptose Biosciences | 1.4 | $2.6M | 453k | 5.67 | |
| Equinox Gold Corp equities (EQX) | 1.2 | $2.3M | 300k | 7.69 | |
| Walt Disney Company (DIS) | 1.2 | $2.2M | 15k | 144.60 | |
| Rocket Pharmaceuticals (RCKT) | 1.1 | $2.0M | 89k | 22.76 | |
| Bellus Health | 0.9 | $1.7M | 220k | 7.60 | |
| Gold Fields (GFI) | 0.9 | $1.7M | 250k | 6.60 |
